108 related articles for article (PubMed ID: 6197837)
1. Proliferative responses of fibroblasts from psoriatic and normal skin to clobetasol propionate.
Priestley GC; Adams LW; Oakley CA; Prescott RJ
Acta Derm Venereol; 1983; 63(5):393-6. PubMed ID: 6197837
[TBL] [Abstract][Full Text] [Related]
2. Effects of corticosteroids on the growth and metabolism of fibroblasts cultured from human skin.
Priestley GC
Br J Dermatol; 1978 Sep; 99(3):253-61. PubMed ID: 81679
[TBL] [Abstract][Full Text] [Related]
3. [Antiproliferative activity of a highly purified coal tar preparation in comparison with clobetasol-17-propionate].
Bernd A; Theilig C; Müller K; Bereiter-Hahn J; Hevert F; Holzmann H
Arzneimittelforschung; 1990 Jul; 40(7):782-7. PubMed ID: 2145840
[TBL] [Abstract][Full Text] [Related]
4. [Comparative study of diflorasone diacetate and clobetasol-17-propionate in PUVA-resistant psoriasis].
Rozman TA; Wiedey KD; Renovanz HD
Z Hautkr; 1983 Mar; 58(6):398-409. PubMed ID: 6342288
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast function in psoriatic arthritis. I. Alteration of cell kinetics and growth factor responses.
Espinoza LR; Aguilar JL; Espinoza CG; Cuéllar ML; Scopelitis E; Silveira LH
J Rheumatol; 1994 Aug; 21(8):1502-6. PubMed ID: 7983654
[TBL] [Abstract][Full Text] [Related]
6. Effects of glucocorticosteroids on cultured human skin fibroblasts. V. Influence of anabolic steroids on the inhibitory effects of clobetasol-17-propionate on cell proliferation and collagen synthesis.
Ponec M; de Haas C; Kempenaar JA; Bachra BN
Arch Dermatol Res; 1979 Aug; 266(1):75-82. PubMed ID: 507931
[TBL] [Abstract][Full Text] [Related]
7. Effects of topically applied clobetasol-17-propionate on histamine release in human skin.
Ståhle M; Hägermark O
Acta Derm Venereol; 1984; 64(3):239-42. PubMed ID: 6204486
[TBL] [Abstract][Full Text] [Related]
8. Atrophic skin striae following the use of clobetasol propionate ointment.
Hardie RA; Waring AJ; Barnetson RS
Practitioner; 1977 Sep; 219(1311):376-8. PubMed ID: 928283
[No Abstract] [Full Text] [Related]
9. [Double-blind-study on treatment with clobetasol-17-propionate and other topical corticoids (author's transl)].
Beck M; Berger C; Filipp N; Hundertmark U; Loewel R
Z Hautkr; 1981 Aug; 56(16):1066-70. PubMed ID: 7027655
[TBL] [Abstract][Full Text] [Related]
10. The effect on psoriasis of clobetasol propionate used alone or in combination with UVB.
Larkö O; Swanbeck G; Svartholm H
Acta Derm Venereol; 1984; 64(2):151-4. PubMed ID: 6203304
[TBL] [Abstract][Full Text] [Related]
11. A double-blind comparison of quarter strength clobetasol propionate in Unguentum Merck with betamethasone valerate in psoriasis.
Stankler L
Br J Clin Pract; 1983; 37(11-12):389-91. PubMed ID: 6367795
[No Abstract] [Full Text] [Related]
12. Intrinsic potencies of novel thiol ester corticosteroids RS-85095 and RS-21314 as compared with clobetasol 17-propionate and fluocinonide.
Ong JT; Poulsen BJ; Akers WA; Scholtz JR; Genter FC; Kertesz DJ
Arch Dermatol; 1989 Dec; 125(12):1662-5. PubMed ID: 2589861
[TBL] [Abstract][Full Text] [Related]
13. Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis.
Reygagne P; Mrowietz U; Decroix J; de Waard-van der Spek FB; Acebes LO; Figueiredo A; Caputo R; Poncet M; Arsonnaud S
J Dermatolog Treat; 2005 Feb; 16(1):31-6. PubMed ID: 15897165
[TBL] [Abstract][Full Text] [Related]
14. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two application schedules for clobetasol 17 propionate.
vd Harst LC; de Jonge H; Pot F; Polano MK
Acta Derm Venereol; 1982; 62(3):270-3. PubMed ID: 6179380
[No Abstract] [Full Text] [Related]
16. Expression of vitamin D receptor in cultured human keratinocytes and fibroblasts is not altered by corticosteroids.
Midorikawa K; Sayama K; Shirakata Y; Hanakawa Y; Sun L; Hashimoto K
J Dermatol Sci; 1999 Sep; 21(1):8-12. PubMed ID: 10468186
[TBL] [Abstract][Full Text] [Related]
17. Effects of glucocorticosteroids on cultured human skin fibroblasts--IV. Specific decrease in the synthesis of collagen but no effect on its hydroxylation.
Ponec M; Kempenaar JA; Van Der Meulen-Van Harskamp GA; Bachra BN
Biochem Pharmacol; 1979 Sep; 28(18):2777-83. PubMed ID: 227415
[No Abstract] [Full Text] [Related]
18. Topical application of clobetasol-17-propionate inhibits the intra-epidermal accumulation of polymorphonuclear leukocytes.
Chang A; van de Kerkhof PC
Acta Derm Venereol; 1988; 68(1):57-60. PubMed ID: 2449013
[TBL] [Abstract][Full Text] [Related]
19. Generalized pustular psoriasis associated with withdrawal of topical clobetasol-17-propionate.
Telfer NR; Dawber RP
J Am Acad Dermatol; 1987 Jul; 17(1):144-5. PubMed ID: 3611449
[No Abstract] [Full Text] [Related]
20. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
